- Home
- IGC vs MDCX Comparison
IGC vs MDCX Comparison
Compare IGC & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- MDCX
- Stock Information
- Founded
- IGC 2005
- MDCX 2008
- Country
- IGC United States
- MDCX United States
- Employees
- IGC N/A
- MDCX N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- MDCX
- Sector
- IGC Health Care
- MDCX
- Exchange
- IGC Nasdaq
- MDCX Nasdaq
- Market Cap
- IGC 39.8M
- MDCX 36.2M
- IPO Year
- IGC N/A
- MDCX N/A
- Fundamental
- Price
- IGC $0.42
- MDCX $2.44
- Analyst Decision
- IGC Strong Buy
- MDCX Strong Buy
- Analyst Count
- IGC 2
- MDCX 2
- Target Price
- IGC $4.00
- MDCX $23.50
- AVG Volume (30 Days)
- IGC 695.2K
- MDCX 410.3K
- Earning Date
- IGC 11-11-2025
- MDCX 11-22-2025
- Dividend Yield
- IGC N/A
- MDCX N/A
- EPS Growth
- IGC N/A
- MDCX N/A
- EPS
- IGC N/A
- MDCX N/A
- Revenue
- IGC $1,327,000.00
- MDCX N/A
- Revenue This Year
- IGC $15.26
- MDCX N/A
- Revenue Next Year
- IGC $3.41
- MDCX N/A
- P/E Ratio
- IGC N/A
- MDCX N/A
- Revenue Growth
- IGC 24.95
- MDCX N/A
- 52 Week Low
- IGC $0.25
- MDCX $1.79
- 52 Week High
- IGC $0.50
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- IGC 52.73
- MDCX 49.21
- Support Level
- IGC $0.39
- MDCX $2.33
- Resistance Level
- IGC $0.43
- MDCX $2.62
- Average True Range (ATR)
- IGC 0.02
- MDCX 0.23
- MACD
- IGC -0.00
- MDCX -0.02
- Stochastic Oscillator
- IGC 44.42
- MDCX 23.22
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.